At KLAVA Innovation, we are transforming healthcare by developing digital therapies (DTx) to treat patients with addictive disorders.
Together, let's reshape healthcare
At KLAVA Innovation, we are transforming healthcare by developing digital therapeutics (DTx) to treat patients with addictive disorders.
Developing a digital treatment to overcome addictions
Clinical trial
Making the patient the master of their own care by assessing their level of dependence via clinically validated self-assessment questionnaires and by declaring symptoms on their smartphone.
Patient monitoring
Our solution takes care of remote patient monitoring allowing professionals to assess the evolution of their patients' health. Thanks to the data collection, the doctor will be able to optimize the treatment and thus limit the " cravings ".
Treatment and assistance
Combined with digital therapeutics, the patient is assisted throughout his treatment, limiting the risk of relapse between two consultations.
The high risk of relapse related to
addictions in the world
Addictive pathologies face a particularly significant “treatment gap”. Among psychiatric pathologies, they represent those with the highest “treatment gap” rates in most countries.
Whether it’s a problem with alcohol, tobacco or any other substance, addiction kills thousands of people every year and impacts millions of lives.
The high risk of relapse related to addictions in the world
Addictive pathologies face a particularly significant “treatment gap”. Among psychiatric pathologies, they represent those with the highest “treatment gap” rates in most countries.
Whether it’s a problem with alcohol, tobacco or any other substance, addiction kills thousands of people every year and impacts millions of lives.
1.3
Smokers in the world
+7
Deaths per year due to smoking
240
People suffer from alcohol use disorders
3M
Deaths every year due to harmful use of alcohol
KLAVA Innovation uses facial recognition technology to track emotional charge
About KLAVA Innovation
Our mission at KLAVA Innovation is to improve the health of millions of people with addictions worldwide.
In the field of neuroscience, facial expressions can provide healthcare professionals with clinical information on the emotional state of their patients. Alteration or modification of these expressions could be powerful markers for the detection and monitoring of these disorders.
In addictology, our capacity for innovation is based on facial recognition in the monitoring of emotions to detect relapses at an early stage.
In addition to conventional drugs, KLAVA Innovation is developing digital therapeutic solutions likely to offer new alternatives to patients and healthcare professionals currently facing unmet medical needs in these fields.
KLAVA Innovation uses facial recognition technology to track emotional charge
About KLAVA Innovation
Our mission at KLAVA Innovation is to improve the health of millions of people with addictions worldwide.
In the field of neuroscience, facial expressions can provide healthcare professionals with clinical information on the emotional state of their patients. Alteration or modification of these expressions could be powerful markers for the detection and monitoring of these disorders.
In addictology, our capacity for innovation is based on facial recognition in the monitoring of emotions to detect relapses at an early stage.
In addition to conventional drugs, KLAVA Innovation is developing digital therapeutic solutions likely to offer new alternatives to patients and healthcare professionals currently facing unmet medical needs in these fields.
Our partners
By our side, one of the most prestigious Addiction department in France – the Addiction Department – Paul-Brousse Hospital – AP-HP in Villejuif (Val-de-Marne).
The Addiction Center of Paul-Brousse Hospital is a renowned center for the evaluation and treatment of addictions. It receives nearly 100 patients per day. A multidisciplinary approach is adopted in this center, combining research, care and teaching excellence.
